Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO study.

Harm reduction journal·2026
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO study.

Drug and alcohol dependence·2026
Same author

Immune Checkpoint Inhibition Therapy Beyond the Tumor: Implications for Hepatitis B Virus in Hepatocellular Carcinoma.

The Journal of infectious diseases·2026
Same author

Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO Study.

International journal of environmental research and public health·2026
Same journal

CORRIGENDUM TO: Recent advances in the diagnosis and management of pre-eclampsia.

F1000prime reports·2015
Same journal

Ethylene receptors in plants - why so much complexity?

F1000prime reports·2015
Same journal

Hematopoietic transcription factor mutations and inherited platelet dysfunction.

F1000prime reports·2015
Same journal

Advancing our knowledge of the complexity and management of intimate partner violence and co-occurring mental health and substance abuse problems in women.

F1000prime reports·2015
Same journal

Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.

F1000prime reports·2015
Same journal

Insomnia and sleep apnea in midlife women: prevalence and consequences to health and functioning.

F1000prime reports·2015
See all related articles

Related Experiment Video

Updated: May 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Management algorithm for genotype 1 hepatitis C virus.

Arthur Y Kim1

  • 1Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts 02114 USA.

F1000Prime Reports
|July 19, 2013
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) infection management is improving with new therapies. This guide offers a framework for clinicians treating HCV genotype 1, addressing knowledge gaps for better patient outcomes.

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: May 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

  • Hepatology and Viral Gastroenterology
  • Clinical Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease globally.
  • Increasing morbidity and mortality associated with HCV-related end-stage liver disease.
  • Emergence of novel therapeutics offers improved cure rates but faces implementation challenges.

Purpose of the Study:

  • To provide a management framework for Hepatitis C virus (HCV) genotype 1 infection.
  • To address the deficit in provider knowledge regarding novel HCV therapeutics.
  • To guide initial clinical decisions for the most common HCV genotype.

Main Methods:

  • Development of a general framework and clinical algorithms.
  • Focus on therapies approved as of 2013 for HCV genotype 1.
  • Guidance for initial management decisions.

Main Results:

  • Provides a structured approach to managing HCV genotype 1.
  • Aims to bridge the knowledge gap among healthcare providers.
  • Facilitates the effective application of new HCV treatments.

Conclusions:

  • Effective management of HCV genotype 1 requires updated provider knowledge.
  • Algorithmic guidance can support the optimal use of novel HCV therapies.
  • Addressing provider education is crucial for mitigating HCV-related liver disease.